Title: Basu D, et al. Identification, mechanism of action, and antitumor activity of a small molecule inhibitor of hippo, TGF-β, and Wnt signaling pathways. Mol Cancer Ther. 2014 Jun;13(6):1457-67.
439144-66-8 | IMD-0560 | AA01EO7G | MFCD31630827
55476-47-6 | 10-Tosyl-10H-phenoxazine | AA01EOEH | MFCD01646529
1334294-76-6 | GSK682753A | AA01EOK2 | MFCD30738004
2131798-13-3 | GSK656 | AA01EOP8 | MFCD31657361
2108899-91-6 | 2-[4-(4-chlorophenyl)-2-thiazolyl]hydrazone-cyclopentanone,monohydrochloride | AA01EOX8
182135-66-6 | 4-[[[5,6-dihydro-5,5-dimethyl-8-(3-quinolinyl)-2-naphthalenyl]carbonyl]amino]-benzoicacid | AA01EP7T | MFCD00952209
927635-64-1 | (αR,4R)-rel-2-amino-6-bromo-α-cyano-3-(ethoxycarbonyl)-4H-1-benzopyran-4-aceticacid,ethylester | AA01EPFY
1201918-15-1 | N-[(3α,5β,7α,12α)-3,7,12-trihydroxy-24-oxocholan-24-yl-2,2,4,4-d4]-glycine | AA01EPLC | MFCD01861560
1562369-96-3 | N-[(3Z)-9-methyl-1-oxo-3-decen-1-yl]-L-α-aspartyl-(2S,3R)-2,3-diaminobutanoyl-(2R)-2-piperidinecarbonyl-(3S)-3-methyl-L-α-aspartyl-L-α-aspartylglycyl-L-α-aspartylglycyl-(2R,3R)-2,3-diaminobutanoyl-L-valyl-L-proline(11→2)-lactam | AA01EPS2
89911-69-3 | N-acetyl-L-α-aspartyl-O-sulfo-L-tyrosyl-L-methionylglycyl-L-tryptophanamide | AA01EQ0T
